Atlas Trials

Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

Clinical trial NCT06933134 · RECRUITING

Trial details

NCT number
NCT06933134
Sponsor
University Hospital, Tours
Status
RECRUITING
Study type
OBSERVATIONAL
Rheumatoid Arthritis (RA)
Start date
2026-04-23
Primary completion
2028-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.